Javascript must be enabled to continue!
Metronidazole-induced neurotoxicity: is iron a contributing factor?
View through CrossRef
Abstract
Background
Metronidazole-induced neurotoxicity is a rising challenge in the management of susceptible infections. The mechanisms involved in metronidazole-induced neurotoxicity are not fully unraveled. This study was aimed at determining the effect of metronidazole on iron homeostasis in SH-SY-5Y neuroblastoma cells.
Methods
Confluent SH-SY-5Y neuroblastoma cells were treated with 1, 10, 25, 50, 100, 250 µM concentrations of metronidazole only or in combination with 20 µM iron. DMSO or culture media was used as control. Viability and ferritin assay were conducted on the treated cells. The treatments were for 24 hr, 48 hr and 72 hr respectively.
Results
In the viability assay, doses of metronidazole reduced viability of SH-SY-5Y neuroblastoma cells in a time and concentration dependent manner. After 24 hr treatment, 250 µM metronidazole reduced (P < 0.001) cell viability while 50 µM, 100 µM and 250 µM metronidazole reduced (p < 0.01, p < 0.001) viability only after 48 and 72 hr compared with control. Doses of metronidazole 50 µM, 100 µM and 250 µM in 20 µM iron reduced viability in a time dependent manner in all the tests periods. Metronidazole also induced a time and concentration dependent increase (P < 0.05) in cellular iron uptake in the 48 and 72 hr treated cells in concentrations above 25 µM metronidazole.
Conclusion
It is concluded that metronidazole induces a time and concentration dependent iron overload and consequent cell death in SH-SY5Y neuroblastoma cells and this may contribute to the mechanism of metronidazole-induced neurotoxicity.
Springer Science and Business Media LLC
Title: Metronidazole-induced neurotoxicity: is iron a contributing factor?
Description:
Abstract
Background
Metronidazole-induced neurotoxicity is a rising challenge in the management of susceptible infections.
The mechanisms involved in metronidazole-induced neurotoxicity are not fully unraveled.
This study was aimed at determining the effect of metronidazole on iron homeostasis in SH-SY-5Y neuroblastoma cells.
Methods
Confluent SH-SY-5Y neuroblastoma cells were treated with 1, 10, 25, 50, 100, 250 µM concentrations of metronidazole only or in combination with 20 µM iron.
DMSO or culture media was used as control.
Viability and ferritin assay were conducted on the treated cells.
The treatments were for 24 hr, 48 hr and 72 hr respectively.
Results
In the viability assay, doses of metronidazole reduced viability of SH-SY-5Y neuroblastoma cells in a time and concentration dependent manner.
After 24 hr treatment, 250 µM metronidazole reduced (P < 0.
001) cell viability while 50 µM, 100 µM and 250 µM metronidazole reduced (p < 0.
01, p < 0.
001) viability only after 48 and 72 hr compared with control.
Doses of metronidazole 50 µM, 100 µM and 250 µM in 20 µM iron reduced viability in a time dependent manner in all the tests periods.
Metronidazole also induced a time and concentration dependent increase (P < 0.
05) in cellular iron uptake in the 48 and 72 hr treated cells in concentrations above 25 µM metronidazole.
Conclusion
It is concluded that metronidazole induces a time and concentration dependent iron overload and consequent cell death in SH-SY5Y neuroblastoma cells and this may contribute to the mechanism of metronidazole-induced neurotoxicity.
Related Results
ANALISIS PERTIMBANGAN MAHKAMAH AGUNG DALAM MENGABULKAN KASASI TERDAKWA (STUDI PUTUSAN NOMOR 2959/K/PID.SUS/2022)
ANALISIS PERTIMBANGAN MAHKAMAH AGUNG DALAM MENGABULKAN KASASI TERDAKWA (STUDI PUTUSAN NOMOR 2959/K/PID.SUS/2022)
<p><em><span class="markedContent"><span style="left: calc(var(--scale-factor)*195.53px); top: calc(var(--scale-factor)*496.87px); font-size: calc(var(--scale-...
Improving metronidazole prescription practices in surgical patients: a full cycle audit
Improving metronidazole prescription practices in surgical patients: a full cycle audit
ABSTRACT
Introduction
Metronidazole is commonly prescribed for intra-abdominal infections. Oral metronidazole has high bioavaila...
1010. Metronidazole-associated neurologic adverse events: risk factors analysis
1010. Metronidazole-associated neurologic adverse events: risk factors analysis
Abstract
Background
Metronidazole is a widely used antibiotic to treat anaerobic and protozoal infections. However, neurologic a...
KEDUDUKAN AHLI BAHASA DALAM PEMBUKTIAN PERKARA PENCEMARAN NAMA BAIK (STUDI PUTUSAN NOMOR: 47/PID.SUS/2019/PN. MGT)
KEDUDUKAN AHLI BAHASA DALAM PEMBUKTIAN PERKARA PENCEMARAN NAMA BAIK (STUDI PUTUSAN NOMOR: 47/PID.SUS/2019/PN. MGT)
<em><span id="page3R_mcid52" class="markedContent"><span style="left: calc(var(--scale-factor)*125.30px); top: calc(var(--scale-factor)*539.11px); font-size: calc(va...
Metronidazole Increases Intracolonic but Not Peripheral Blood Acetaldehyde in Chronic Ethanol‐Treated Rats
Metronidazole Increases Intracolonic but Not Peripheral Blood Acetaldehyde in Chronic Ethanol‐Treated Rats
Background: Metronidazole leads to the overgrowth of aerobic flora in the large intestine by reducing the number of anaerobes. According to our previous studies, this shift may in...
Metronidazole-Induced Pancreatitis: Is There Underrecognition? A Case Report and Systematic Review of the Literature
Metronidazole-Induced Pancreatitis: Is There Underrecognition? A Case Report and Systematic Review of the Literature
Introduction. Acute pancreatitis (AP) is the most common cause of gastroenterological hospitalization in the USA, with a mortality ranging from 5 to 20%. Up to 80% of cases are cau...
Iron stress affects the survival of Toxoplasma gondii
Iron stress affects the survival of Toxoplasma gondii
Abstract
Background
Iron possesses redox abilities and plays a crucial role in in biosynthesis, energy metabolism, and other biological processes. It represents an indispe...
Iron Chelation Efficiency in Human Hepatocytes Is Enhanced By Exogenous Hepcidin
Iron Chelation Efficiency in Human Hepatocytes Is Enhanced By Exogenous Hepcidin
Iron chelation is clinically inefficient, with only a small percentage of the applied chelator being excreted in the iron-bound form. Chelation is also slow because only a small pr...

